Noncoding RNAs in gastric cancer: implications for drug resistance
L Wei, J Sun, N Zhang, Y Zheng, X Wang, L Lv, J Liu… - Molecular cancer, 2020 - Springer
Gastric cancer is the fourth most common malignancy and the third leading cause of cancer-
related deaths worldwide. Advanced gastric cancer patients can notably benefit from …
related deaths worldwide. Advanced gastric cancer patients can notably benefit from …
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
L Wei, X Wang, L Lv, J Liu, H ** genes, primarily involved in the regulation of ribosome biogenesis …
Expression profiles of small non-coding RNAs in breast cancer tumors characterize clinicopathological features and show prognostic and predictive potential
E Kärkkäinen, S Heikkinen, M Tengström… - Scientific Reports, 2022 - nature.com
Precision medicine approaches are required for more effective therapies for cancer. As
small non-coding RNAs (sncRNAs) have recently been suggested as intriguing candidates …
small non-coding RNAs (sncRNAs) have recently been suggested as intriguing candidates …
Long non-coding RNA TUG1 promotes cell progression in hepatocellular carcinoma via regulating miR-216b-5p/DLX2 axis
Q Dai, J Deng, J Zhou, Z Wang, X Yuan, S Pan… - Cancer cell …, 2020 - Springer
Background Accumulating evidence indicates that the long noncoding RNA taurine
upregulated gene 1 (TUG1) plays a critical role in cancer progression and metastasis …
upregulated gene 1 (TUG1) plays a critical role in cancer progression and metastasis …